HPV+ head and neck cancer | News Search

跳至主要内容

MedPath Trial Home

机构资讯 AI 研究

数据来源：ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

搜索试验。追踪管线。洞察审批。由 AI 驱动的临床研究情报平台。

产品

临床试验
药物情报
全球审批
深度研究
价格方案

资源

常见问题
搜索

公司

资讯
关于我们
联系我们

法律

隐私政策
服务条款

免责声明： 本网站提供信息检索和数据分析服务。内容不构成医疗建议。适应性评估仅供参考，不能替代合格医疗专业人员的咨询。数据来源于公共注册库和监管机构；MedPath 不保证数据的完整性或准确性。请以原始资料为准。

© 2026 MedPath Trial 版权所有

服务条款隐私政策

我们重视您的隐私

我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。

找到 429,584 条关于 “HPV+ head and neck cancer”

Outrun Therapeutics Advances First-in-Class E6AP Inhibitor for HPV-Positive Head and Neck Cancer

Aprea Therapeutics Advances APR-1051 Clinical Trial with First HPV+ Head and Neck Cancer Patient Dosed

BioNTech's BNT113 mRNA Cancer Vaccine Advances in Phase 2 Trial for HPV+ Head and Neck Cancer

Ultrasensitive Blood Test HPV-DeepSeek Predicts Recurrence and Survival in HPV-Associated Head and Neck Cancer

Revolutionary Blood Test Achieves 99% Accuracy in Detecting HPV-Associated Head and Neck Cancers

Cholesterol Drug Fenofibrate Shows Promise in Treating HPV-Related Cancers

Nykode Therapeutics Advances AI-Powered Immunotherapy Platform with Strong Clinical Progress

Transgene's TG4050 Achieves 100% Two-Year Disease-Free Survival in Head and Neck Cancer Phase I Trial

CUE-101 Combination Therapy Achieves 50% Response Rate in HPV+ Head and Neck Cancer Trial

PDS Biotech's VERSATILE-003 Phase 3 Trial for HPV16-Positive Head and Neck Cancer to Initiate Q1 2025

第 1 页，共 4079 页